San Francisco startup Structure Therapeutics is also working on an oral, as soon as-each day GLP-one drug called GSBR-1290—the drug surpassed Wall Street’s anticipations in June any time a mid-stage review showed common weight loss of close to six% and it strategies to begin A different mid-stage trial in direction of the end of the calendar ye